Clinical Trial Update: Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ferrochelating treatment in patients with neurodegeneration with brain iron accumulation (NBIA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Neurodegenerative Disease

Drugs mentioned

• Ferrochelating treatment

Snippet

Sponsor: Ente Ospedaliero Ospedali Galliera | Conditions: Neurodegenerative Disease, Iron Overload | Phase 2 | Status: UNKNOWN